Frequency of somatic TP53 mutations in non-small cell lung cancer in Kazakhstan

被引：0
|
作者：
Zhuraliyeva, A. [1 ]
Wang, J. [2 ]
Khamdiyeva, O. [1 ]
Abdullaev, Z. [2 ]
Pack, S. [2 ]
Biyasheva, Z. [1 ]
机构：
[1] Al Farabi Kazakh Natl Univ, Sci Res Inst Issues Biol & Biotechnol, Alma Ata, Kazakhstan
[2] NCI, Pathol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
FEBS OPEN BIO | 2019年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-35-114
引用
收藏
页码：354 / 354
页数：1
相关论文
共 50 条
  • [1] TP53 Mutations in Korean Patients with Non-small Cell Lung Cancer
    Lee, Eung Bae
    Jin, Guang
    Lee, Shin Yup
    Park, Ji Young
    Kim, Min Jung
    Choi, Jin Eun
    Jeon, Hyo Sung
    Cha, Seung Ick
    Cho, Sukki
    Kim, Chang Ho
    Park, Tae-In
    Jung, Tae Hoon
    Son, Ji-Woong
    Park, Jae Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (05) : 698 - 705
  • [2] Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism
    Szymanowska, A
    Jassem, E
    Dziadziuszko, R
    Borg, A
    Limon, J
    Kobierska-Gulida, G
    Rzyman, W
    Jassem, J
    LUNG CANCER, 2006, 52 (01) : 9 - 14
  • [3] TP53 somatic mutations are associated with poor survival in non-small cell lung cancer patients who undergo immunotherapy
    Zhao, Liqin
    Qu, Xiaofei
    Wu, Zhenhua
    Li, Yuehua
    Zhang, Xiaowei
    Guo, WeiJian
    AGING-US, 2020, 12 (14): : 14556 - 14568
  • [4] Frequency of TP53 mutations in relation to Arg72Pro genotypes in non-small cell lung cancer
    Lind, Helge
    Ekstrom, Per Olaf
    Ryberg, David
    Skaug, Vidar
    Andreassen, Tove
    Stangeland, Lodve
    Haugen, Aage
    Zienolddiny, Shanbeh
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (10) : 2077 - 2081
  • [5] Polymorphisms in Apoptosis-Related Genes and TP53 Mutations in Non-Small Cell Lung Cancer
    Bae, Eun Young
    Lee, Eun Jin
    Kang, Hyo-Gyoung
    Lee, Shin Yup
    Jin, Gwang
    Lee, Won Kee
    Choi, Jin Eun
    Jeon, Hyo-Sung
    Lim, Jeong Ok
    Lee, Eung Bae
    Park, Jae Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (11) : 1527 - 1530
  • [6] Association of TP53 Mutations with Response to Anlotinib Treatment in Advanced Non-Small Cell Lung Cancer
    Fang, Shencun
    Cheng, Wanwan
    Zhang, Meiling
    Yang, Rusong
    ONCOTARGETS AND THERAPY, 2020, 13 : 6645 - 6650
  • [7] TP53 mutation, allelism and survival in non-small cell lung cancer
    Nelson, HH
    Wilkojmen, M
    Marsit, CJ
    Kelsey, KT
    CARCINOGENESIS, 2005, 26 (10) : 1770 - 1773
  • [8] Characterization of TP53 mutations in actionable driver-negative non-small cell lung cancer (NSCLC)
    Chi, Jie
    Gandhi, Nishant
    Halmos, Balasz
    Liu, Stephen V.
    Ma, Patrick C.
    Elliott, Andrew
    Vanderwalde, Ari M.
    Mamdani, Hirva
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Exploring the utility of TP53 mutations as prognostic markers in patients with non-small cell lung cancer (NSCLC)
    Wang, Y.
    Zuo, J.
    Feng, L.
    Fan, Z.
    Wang, L.
    Zhang, X.
    Han, J.
    Zhou, X.
    Ye, J.
    Li, B.
    Lizaso, A.
    Zhou, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S799 - S800
  • [10] Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer
    Cho, Sukki
    Kim, Min Jung
    Choi, Yi Young
    Yoo, Seung Soo
    Lee, Won Kee
    Lee, Eun Jin
    Jang, Eun Jeong
    Bae, Eun Young
    Jin, Guang
    Jeon, Hyo-Sung
    Lee, Shin Yup
    Cha, Sung-Ick
    Park, Tae In
    Kim, Chang Ho
    Park, Jae Yong
    LUNG CANCER, 2011, 73 (01) : 25 - 31
12345